For in vitro diagnostic use. Others Elecsys free betahCG IVD Elecsys® free βhCG CPS_000470 04 854 071 200 4 854 071 200 04854071200 4854071200 04854071200 Free HCGbeta Elecsys cobas e 100 Elecsys free beta hCG 04015630922406 Reagents, kits 100 tests cobas e 411/601/602 true 07 027 303 190 7 027 303 190 07027303190 7027303190 07027303190 Free HCGbeta Elecsys E2G 100 Elecsys free beta hCG 04015630940202 Reagents, kits 100 tests cobas e 402/801 true 08 860 319 190 8 860 319 190 08860319190 8860319190 08860319190 Free HCGbeta Elecsys E2G 100 V2 Elecsys free beta hCG 07613336168912 Reagents, kits 100 tests cobas e 402/801 true 08 860 297 190 8 860 297 190 08860297190 8860297190 08860297190 Free HCGbeta Elecsys cobas e 100 V2 Elecsys free beta hCG 07613336168905 Reagents, kits 100 tests cobas e 411/601/602 true ms_04854071200 Elecsys free βhCG en 9 FF00000002771E0E FF00000000219F0E 04854071200 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of free βhCG (free β‑subunit of human chorionic gonadotropin) in human serum. This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027303500 Elecsys free βhCG en 3 FF000000023BBE0E FF0000000193B80E 07027303190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of free βhCG (free β‑subunit of human chorionic gonadotropin) in human serum. This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08860319500 Elecsys free βhCG en 5 FF00000005B19D0E FF0000000431650E 08860319190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of free βhCG (free β‑subunit of human chorionic gonadotropin) in human serum. This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08860297500 Elecsys free βhCG en 3 FF00000005B1D10E FF00000003AFA90E 08860297190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of free βhCG (free β‑subunit of human chorionic gonadotropin) in human serum. This assay is intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome) during the first trimester of pregnancy. Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User Profile

Select your user profile

Elecsys^® free βhCG

Overview

Ordering Information

Technical Documents

Access important product documentation including relevant certificates and other resources.

Compatible Instruments

Related products

Contact us